PATENT CLAIM ANALYSIS

Application Number: 15982904
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-04
Patent Classification: ["514", "378000"]

Abstract:
A soft chewable pharmaceutical product for delivery of a pharmaceutically acceptable active ingredient to an animal comprising pamoic acid or a pharmaceutically acceptable salt and a process for the manufacture of such soft chewable pharmaceutical product.

Claim (Index 10):
The product according to  claim 7  wherein the active pharmaceutical ingredient is 4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]-2-methyl-N-(thietan-3-yl)benzamide.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 93.0
- Lexical Diversity: 1.37037
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14082813', '14390052', '14977680', '13754969', '15936778']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7884588780532715
- 35 USC 102 Novelty (BERT): 0.5181925660533181
- Combined Prediction Score: 0.7614322468532763
- Mean Citation Score: 261.38938
- Max Citation Score: 325.0821200000001
- Similarity Product: 281.3918548419333

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test